FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.ebm
Resource TypeComposition
IdComposition-568070.json
FHIR VersionR6

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: Composition 568070

version: 7; Last updated: 2026-07-23 15:40:12+0000

Profile: M11ReportSection13

Artifact Description:

Example of M11ReportSection13 Profile

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/Composition/568070

identifier: FEvIR Object Identifier/568070

status: Final

type: CeSHarP Report

category: section13-glossary

date: 2026-07-23 15:40:12+0000

author: Brian S. Alper, MD, MSPH

title: M11 Report Section 13 (Glossary) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

custodian: Computable Publishing LLC

relatesTo

type: Derived from

target: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

relatesTo

type: Cite As

target:

M11 Report Section 13 (Glossary) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568070. Revised 2026-07-23. Available at: https://fevir.net/resources/Composition/568070. Computable resource at: https://fevir.net/resources/Composition/568070#json.


Source1

{
  "resourceType": "Composition",
  "id": "568070",
  "meta": {
    "versionId": "7",
    "lastUpdated": "2026-07-23T15:40:12.859Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/m11-report-section-13"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-description",
      "valueMarkdown": "Example of M11ReportSection13 Profile"
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "url": "https://fevir.net/resources/Composition/568070",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "568070",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "status": "final",
  "type": {
    "coding": [
      {
        "system": "http://loinc.org",
        "code": "35528-9",
        "display": "Clinical trial protocol Clinical trial protocol"
      }
    ],
    "text": "CeSHarP Report"
  },
  "category": [
    {
      "coding": [
        {
          "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "code": "C218670",
          "display": "ICH M11 Protocol Section 13 APPENDIX: GLOSSARY OF TERMS AND ABBREVIATIONS"
        }
      ],
      "text": "section13-glossary"
    }
  ],
  "subject": [
    {
      "reference": "ResearchStudy/267245",
      "type": "ResearchStudy",
      "display": "A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"
    }
  ],
  "date": "2026-07-23T15:40:12.859Z",
  "author": [
    {
      "display": "Brian S. Alper, MD, MSPH"
    }
  ],
  "title": "M11 Report Section 13 (Glossary) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example",
  "custodian": {
    "reference": "Organization/118079",
    "type": "Organization",
    "display": "Computable Publishing LLC"
  },
  "relatesTo": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type",
            "code": "derived-from",
            "display": "Derived from"
          }
        ]
      },
      "targetReference": {
        "reference": "ResearchStudy/267245",
        "type": "ResearchStudy",
        "display": "A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"
      }
    },
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type",
            "code": "cite-as",
            "display": "Cite As"
          }
        ]
      },
      "targetMarkdown": "M11 Report Section 13 (Glossary) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568070. Revised 2026-07-23. Available at: https://fevir.net/resources/Composition/568070. Computable resource at: https://fevir.net/resources/Composition/568070#json."
    }
  ],
  "section": [
    {
      "title": "13 APPENDIX: GLOSSARY OF TERMS AND ABBREVIATIONS",
      "code": {
        "coding": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C218670",
            "display": "ICH M11 Protocol Section 13 APPENDIX: GLOSSARY OF TERMS AND ABBREVIATIONS"
          }
        ],
        "text": "section13-glossary"
      },
      "text": {
        "status": "additional",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>3 pages of images replaced with this statement</p></div>"
      }
    }
  ]
}